A definite correlation between the expression of programmed death ligand 1 (PD-L1) in tumor cells and responses to anti-PD-1 has not been clearly demonstrated in HCC, unlike other solid tumors [6]. This evidence concerns the gene CD274 and hepatocellular carcinoma.